BlackRock Capital Allocation Term Trust (NYSE:BCAT) Short Interest Down 93.1% in December

BlackRock Capital Allocation Term Trust (NYSE:BCAT) was the target of a large drop in short interest in the month of December. As of December 31st, there was short interest totaling 43,939 shares, a drop of 93.1% from the December 15th total of 640,429 shares. Currently, 0.0% of the company’s shares are sold short. Based on an average daily trading volume, of 762,139 shares, the days-to-cover ratio is currently 0.1 days. Based on an average daily trading volume, of 762,139 shares, the days-to-cover ratio is currently 0.1 days. Currently, 0.0% of the company’s shares are sold short.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of BCAT. AdvisorNet Financial Inc increased its position in shares of BlackRock Capital Allocation Term Trust by 83.3% in the second quarter. AdvisorNet Financial Inc now owns 1,947 shares of the company’s stock worth $29,000 after acquiring an additional 885 shares in the last quarter. Keener Financial Planning LLC acquired a new stake in BlackRock Capital Allocation Term Trust in the 3rd quarter valued at $29,000. Geneos Wealth Management Inc. lifted its stake in shares of BlackRock Capital Allocation Term Trust by 341.7% during the second quarter. Geneos Wealth Management Inc. now owns 2,045 shares of the company’s stock worth $31,000 after purchasing an additional 1,582 shares in the last quarter. Red Tortoise LLC purchased a new stake in shares of BlackRock Capital Allocation Term Trust in the second quarter worth about $33,000. Finally, McIlrath & Eck LLC grew its stake in shares of BlackRock Capital Allocation Term Trust by 971.1% in the third quarter. McIlrath & Eck LLC now owns 2,999 shares of the company’s stock valued at $44,000 after buying an additional 2,719 shares in the last quarter. 36.12% of the stock is owned by institutional investors and hedge funds.

BlackRock Capital Allocation Term Trust Price Performance

BCAT stock traded up $0.15 during trading on Monday, reaching $14.60. 615,837 shares of the stock traded hands, compared to its average volume of 614,213. The business’s 50 day moving average price is $14.34 and its 200-day moving average price is $14.70. BlackRock Capital Allocation Term Trust has a 52-week low of $12.91 and a 52-week high of $15.91.

BlackRock Capital Allocation Term Trust Dividend Announcement

The firm also recently announced a monthly dividend, which will be paid on Tuesday, March 31st. Investors of record on Friday, March 13th will be given a dividend of $0.2607 per share. This represents a c) dividend on an annualized basis and a yield of 21.4%. The ex-dividend date of this dividend is Friday, March 13th.

About BlackRock Capital Allocation Term Trust

BlackRock Capital Allocation Term Trust (NYSE: BCAT) is a closed-end, diversified management investment company organized as a term trust. The fund’s primary objective is to deliver high current income and total return by investing across a broad range of credit and equity markets. BCAT seeks to achieve this objective through a portfolio of corporate debt securities, floating-rate loans, convertible securities, common and preferred equity, and asset-backed securities.

BCAT employs an actively managed, multi-sector credit approach that spans investment-grade and below-investment-grade bonds, senior secured loans and structured credit.